Bovine Mastitis Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 1.60 Billion |
| Market Size (2029) | USD 2.04 Billion |
| CAGR (2024 - 2029) | 4.88 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Bovine Mastitis Market Analysis
The Bovine Mastitis Market size is estimated at USD 1.60 billion in 2024, and is expected to reach USD 2.04 billion by 2029, growing at a CAGR of 4.88% during the forecast period (2024-2029).
The COVID-19 pandemic had an unprecedented impact on the growth of the bovine mastitis market. In 2020, it significantly impacted the supply chain of products for the treatment of bovine mastitis. Containment measures, such as lockdowns and social distancing, created problems in terms of the availability of medicines due to reduced operations in veterinary pharmacies. However, the relaxation of strict regulations post the pandemic led to the normal functioning of supply chain, which contributed to the market's growth.
The major factors responsible for the growth of the bovine mastitis market include the rising incidences of disease, the increasing product launches for animal healthcare, and technological advancements in the field of drug discovery and development.
Bovine mastitis is one of the major concerns in the dairy industry worldwide. Dairy farmers are facing huge economic losses with the rising incidences of cattle death globally. For instance, as per the data published by the MSD Manual in October 2022, severe mastitis caused by coliforms results in an higher incidence of cow death (30-50%) worldwide. These mortality rates in cows increase the direct and indirect costs, such as diagnostics, milk loss, veterinary services, labor, future milk production losses, and therapeutics. The rising bovine mastitis cases and related market loss are fuelling the demand for antibiotics in the treatment of the condition.
The increasing investments in the development of bovine mastitis treatment are expected to contribute to the market's growth. For instance, in August 2021, Stonehaven Incubates invested in the Anifera to conduct additional studies to explore the impact and effectiveness of adjunct therapy in bovine mastitis.
However, the rising threat of antibiotic resistance and a lack of awareness about the disease are expected to slow the market's growth over the forecast period.
Bovine Mastitis Market Trends
Clinical Mastitis is Expected to Account for the Largest Market Share During the Forecast Period
The clinical mastitis segment is expected to hold a major share due to the high prevalence of clinical mastitis and the growing demand for effective therapeutics. According to a study published in the MDPI Journal in May 2021, the incidence of clinical mastitis in Southern Ethiopia was found to be 9%, 10%, and 10% in cows, camels, and goats, respectively, in 2020. Thus, the high prevalence of clinical mastitis is expected to drive the demand for effective therapeutics, thereby driving the growth of the segment.
The increasing R&D activities for the treatment of clinical mastitis are also expected to contribute to the growth of the segment. For instance, in January 2021, the Institute of Global Food Security at Queen's University launched a research project to tackle bovine clinical mastitis and reduce the broad spectrum of antibiotics in dairy cattle. This project was launched in partnership with AgriSearch and the Agri-Food and Biosciences Institutes (AFBI).
Thus, such factors are expected to contribute to the growth of the segment over the forecast period.
Asia-Pacific is Expected to Hold a Significant Share of the Market During the Forecast Period
Asia-Pacific is expected to hold a major share of the bovine mastitis market over the forecast period without significant fluctuations due to the strong adoption of intra-mammary infusion products for the treatment and the presence of leading players in the region.
The increasing incidence of bovine mastitis in the region is also expected to drive the growth of the market over the forecast period. For instance, according to the data published by Wageningen University and Research in 2022, the prevalence of subclinical mastitis among the cattle population in Sri Lanka, Bangladesh, India, and Pakistan ranged from about 20% to 80%. Such prevalence of bovine mastitis in Asia-Pacific is expected to drive the growth of the market in the region.
The adoption of advanced technologies in the region to manage bovine mastitis is also expected to contribute to the market's growth. For instance, in August 2021, Dairy Australia, Coles, Food Agility CRC, University of Sydney, University Technology Sydney, and Charles Sturt University collaborated to reduce the use of antibiotics in the milk supply chain and improve the health and management of dairy cows with mastitis. These organizations used the clinical mastitis decision support tool project, an AI-powered tool to manage clinical mastitis. Such developments are expected to contribute to the growth of the market in Asia-Pacific over the forecast period.
Bovine Mastitis Industry Overview
The bovine mastitis market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market, including Zoetis, Merck & Co. Inc, Boehringer Ingelheim, Bayer AG, Elanco, Ceva, and West Way Health.
Bovine Mastitis Market Leaders
-
Zoetis Inc.
-
Merck & Co., Inc.
-
Boehringer Ingelheim International GmbH
-
Ceva
-
West Way Health
*Disclaimer: Major Players sorted in no particular order
Bovine Mastitis Market News
- In October 2022, NovaQuest Capital Management invested over USD 20 million in Mileutis Ltd, an Israeli biopharmaceuticals company, to help mitigate the use of antibiotics in animals. Mileutics is in the advanced stages of developing a product that treats and prevents bovine mastitis.
- In August 2022, PortaCheck launched a PortaReader, a handheld device that detects subclinical mastitis cow-side in bovine milk. The PortaReader detects subclinical mastitis in fresh bovine milk samples right on the farm.
Bovine Mastitis Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Incidence of the Disease
- 4.2.2 Increasing Product Launches for Animal Healthcare
- 4.2.3 Technological Advancements in the Field of Drug Discovery and Development
-
4.3 Market Restraints
- 4.3.1 Rising Threat of Antibiotic Resistance
- 4.3.2 Lack of Awareness About the Disease
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type
- 5.1.1 Clinical Mastitis
- 5.1.2 Sub-clinical Mastitis
-
5.2 By Product
- 5.2.1 Antibiotics
- 5.2.2 Surgery
- 5.2.3 Vaccines
- 5.2.4 Pain Killers
- 5.2.5 Other Products
-
5.3 By Route of Administration
- 5.3.1 Intra-mammary
- 5.3.2 Systemic
-
5.4 By Therapy
- 5.4.1 Lactating Period
- 5.4.2 Dry Period
-
5.5 By End User
- 5.5.1 Hospitals and Clinics
- 5.5.2 Veterinary Centers
- 5.5.3 Other End Users
-
5.6 By Geography
- 5.6.1 North America
- 5.6.1.1 United States
- 5.6.1.2 Canada
- 5.6.1.3 Mexico
- 5.6.2 Europe
- 5.6.2.1 Germany
- 5.6.2.2 United Kingdom
- 5.6.2.3 France
- 5.6.2.4 Italy
- 5.6.2.5 Spain
- 5.6.2.6 Rest of Europe
- 5.6.3 Asia-Pacific
- 5.6.3.1 China
- 5.6.3.2 Japan
- 5.6.3.3 India
- 5.6.3.4 Australia
- 5.6.3.5 South Korea
- 5.6.3.6 Rest of Asia-Pacific
- 5.6.4 Middle East and Africa
- 5.6.4.1 GCC
- 5.6.4.2 South Africa
- 5.6.4.3 Rest of Middle East and Africa
- 5.6.5 South America
- 5.6.5.1 Brazil
- 5.6.5.2 Argentina
- 5.6.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Zoetis Inc.
- 6.1.2 Merck & Co. Inc.
- 6.1.3 Boehringer Ingelheim International GmbH
- 6.1.4 Elanco (Bayer AG)
- 6.1.5 Ceva
- 6.1.6 West Way Health
- 6.1.7 Norbrook
- 6.1.8 DeLaval
- 6.1.9 ImmuCell Corporation
- 6.1.10 Advanced Animal Diagnostics
- 6.1.11 Nimrod Veterinary Products Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityBovine Mastitis Industry Segmentation
As per the scope of the report, bovine mastitis is an inflammatory disease of the udder tissue in the mammary gland caused due to physical trauma or microorganism infections. It is considered the most common disease leading to economic loss in dairy industries due to reduced yield and poor quality of milk.
The bovine mastitis market is projected to register a CAGR of 5.1% during the forecast period. the bovine mastitis market is segmented by type (clinical and sub-clinical), product (antibiotics, surgery, vaccines, pain killers, and other products), route of administration (intra-mammary and systemic), therapy (lactating period and dry period), end user (hospitals, veterinary centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally.
| By Type | Clinical Mastitis | |
| Sub-clinical Mastitis | ||
| By Product | Antibiotics | |
| Surgery | ||
| Vaccines | ||
| Pain Killers | ||
| Other Products | ||
| By Route of Administration | Intra-mammary | |
| Systemic | ||
| By Therapy | Lactating Period | |
| Dry Period | ||
| By End User | Hospitals and Clinics | |
| Veterinary Centers | ||
| Other End Users | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Bovine Mastitis Market Research FAQs
How big is the Bovine Mastitis Market?
The Bovine Mastitis Market size is expected to reach USD 1.60 billion in 2024 and grow at a CAGR of 4.88% to reach USD 2.04 billion by 2029.
What is the current Bovine Mastitis Market size?
In 2024, the Bovine Mastitis Market size is expected to reach USD 1.60 billion.
Who are the key players in Bovine Mastitis Market?
Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva and West Way Health are the major companies operating in the Bovine Mastitis Market.
Which is the fastest growing region in Bovine Mastitis Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Bovine Mastitis Market?
In 2024, the North America accounts for the largest market share in Bovine Mastitis Market.
What years does this Bovine Mastitis Market cover, and what was the market size in 2023?
In 2023, the Bovine Mastitis Market size was estimated at USD 1.52 billion. The report covers the Bovine Mastitis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Bovine Mastitis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Bovine Mastitis Industry Report
Statistics for the 2024 Bovine Mastitis market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Bovine Mastitis analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
